<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Acetylcholinesterase (AChE) activity was measured in cerebrospinal fluid (CSF) from 25 patients with senile <z:hpo ids='HP_0000726'>dementia</z:hpo> of Alzheimer type (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>), 11 patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD), 26 patients with <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>), and 30 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="1" pm="."><plain>AChE activity also was measured in 46 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects whose ages ranged from 15 to 85 to evaluate the effect of age on AChE activity </plain></SENT>
<SENT sid="2" pm="."><plain>CSF AChE activity for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>, VD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> groups showed no significant difference compared with the value for the control group </plain></SENT>
<SENT sid="3" pm="."><plain>However, there were significant decreases in CSF AChE activity in the VD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> groups with the development of ventricular enlargement </plain></SENT>
<SENT sid="4" pm="."><plain>There was no significant correlation between CSF AChE activity decrease and ventricular enlargement in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> group </plain></SENT>
<SENT sid="5" pm="."><plain>AChE activity increased significantly over the age range of 15 to 85 </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that, although CSF AChE activity is not a useful parameter in the diagnosis of <z:hpo ids='HP_0000726'>dementia</z:hpo>, it may be a marker indicating abnormalities of the intracerebral cholinergic system during the process of <z:hpo ids='HP_0002059'>cerebral atrophy</z:hpo> </plain></SENT>
</text></document>